Vape products; Alternative Nicotine Products Regulatory Act of 2026; terms; manufacturing, labeling, marketing, and safety requirements; attestation; penalties and suspension; enforcement; Attorney General; Alternative Nicotine Products Compliance Fund; effective date.
HB3881 creates the “Alternative Nicotine Products Regulatory Act of 2026,” a new regulatory framework for vape products and other noncombustible nicotine items sold in Oklahoma. The bill defines “alternative nicotine product,” “e-liquid,” “minor,” and related terms, and then imposes packaging, labeling, and marketing rules on manufacturers, dealers, wholesalers, and retailers. Among other things, e-liquid containers must use child-resistant caps and tamper-evident packaging, labels must carry federally required nicotine addictiveness warnings, and packages must identify ingredients and manufacturer or wholesaler information, with a barcode or QR code allowed for tracking.
The bill also restricts youth-oriented marketing. It bars the use of candy- or dessert-like names, cartoon or superhero references, and branding or trade dress that imitates products or imagery commonly associated with minors, including certain foods, school supplies, devices, clothing, and toys. In addition, manufacturers must file an attestation with the Attorney General showing either FDA marketing authorization or a pending premarket tobacco application meeting specified conditions, pay initial and annual fees, and notify the Attorney General of material changes in FDA status. The bill further requires that consumable material be manufactured, processed, blended, or filled in the United States by January 1, 2028, or the product must be removed from the list of legal products.
HB3881 gives enforcement authority to both the Department of Revenue and the Attorney General. The Department may assess civil penalties of up to $5,000 per violation, while the Attorney General may investigate, seek injunctions, and recover civil penalties of up to $10,000 per violation for certain violations. Civil penalties are deposited into a newly created Alternative Nicotine Products Compliance Fund, which is to be used by the Department and Attorney General for enforcement. The act is set to take effect November 1, 2026, and would amend Title 63 of the Oklahoma Statutes by adding new sections governing alternative nicotine products.
The overall sentiment in committee and on the House floor appears generally supportive but not unanimous. The bill advanced out of the Alcohol, Tobacco and Controlled Substances Committee and the Health and Human Services Oversight Committee, and it passed third reading in the House by a narrower margin than the committee votes. Discussion reflected support framed around public health, parental choice, and fiscal responsibility, suggesting proponents viewed the measure as a consumer protection and enforcement bill.
The main points of contention appear to center on regulatory burden, market access, and the scope of state control over nicotine products. Opponents likely objected to the new fees, enforcement powers, marketing restrictions, and the requirement tied to FDA authorization or pending review, which could limit which products may be sold in Oklahoma. The U.S.-manufacturing requirement by 2028 may also be controversial for industry stakeholders because it could exclude products that do not meet that supply-chain condition.
HB3881 would add a new regulatory chapter to Title 63 governing alternative nicotine products, including vape liquids and related noncombustible nicotine items. It would impose packaging, labeling, marketing, disclosure, and FDA-attestation requirements on manufacturers, dealers, wholesalers, and retailers, create civil penalties and enforcement authority for the Department of Revenue and Attorney General, and establish a dedicated compliance fund to support enforcement. The bill would also affect which products may be legally sold in Oklahoma by conditioning legality on FDA status and, beginning in 2028, U.S.-based manufacturing of consumable material.
Committee and floor action suggest the bill had meaningful support, especially among members emphasizing public health, parental choice, and fiscal responsibility, but it was not broadly unanimous. It passed committee votes comfortably and cleared the House on third reading by a smaller margin, indicating some resistance. The available discussion does not show extended debate, but the recorded comments frame the bill as a protective and enforcement-oriented measure rather than a deregulatory one.
The likely points of contention are the bill’s restrictions on flavored or youth-appealing marketing, the compliance costs and fees imposed on manufacturers, and the Attorney General’s expanded enforcement role. Industry stakeholders may object to the FDA-attestation requirement and the 2028 U.S.-manufacturing mandate because they can limit product availability and raise operational costs. Opponents in the House vote likely viewed the bill as overly restrictive or burdensome, while supporters argued it was needed to protect minors and improve accountability in the nicotine product market.